A Deconsolution for disinfection of emerging pathogenic organisms such as H1N1, Norovirus, Methicillin Resistant Staphylococcus aureus (MRSA), Vancomycin Resistant Enterococcus faecalis (VRE) , Enterobactor aerogenes and E. Coli O157:H7 and ESBL. Proven effective in AOAC test against the Swine and Bird Flu (Avian Influenza A&B), Staphylococcus aureus, Salmonella choleraesuis, Klebsiella pheumoniae, Aspergillus niger, Penicillium variabile, Listeria monocytogenes and Trichtophyton entagrophytes.

Pandemic Control MDF-500 can play an important part in controlling pandemics such Swine and Avian Flus. The formulation can play a critical part in reducing nosocomial infections and the vectors of contamination.

Product Description Highly efficacious and environmentally safe, our High Level Disinfection Products are produced exclusively by Modec, Inc. and compounded specifically for the decontamination and mitigation of high level pathogenic organisms that are often found in medical and other healthcare settings. Approved for use in hospitals as a Bactericide, Virucide, Fungicide, and Disinfectant. The formulation has been extensively tested including Report SAND2005-7833 titled "Inactivation of Various Influenza Strains to Model Avian Influenza (Bird Flu) with Various Disinfection Chemistries".

Technology The US Government developed the underlying technology at Sandia National Laboratories and patented the Formulation pursuant to US Patent 6,566,574 B1. Jymrsa's Disinfection products are commercially manufactured by Modec pursuant to its license 00-C00872 with Sandia Corp.

Yahoo News/60 Minutes Coverage - Super Bugs

Sandia Influenza Inactivation Study and Comparison Data (pdf)

Sandia Test Study against Bovine Corona Virus (SARS)

Modec, Inc., 4725 Oakland Street, Denver, Colorado USA 80239 1-800-967-7887 - 303-373-2696